Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011570 (
depression
)
172,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objectives:
In mood disorders chronic stress contributes to decreased glucocorticoid receptor signalling in the brain and resistance in the periphery. We hypothesised that aberrant glucocorticoid receptor function may result from genetic predisposition and that decreased GR signalling in the brain correlates with the expression of genes regulating GR complex formation.
Methods:
We performed the association analysis of 698 patients: 490 patients with bipolar disorder and 208 patients with major depressive disorder and 564 control subjects. We genotyped 11 variants using TaqMan assays. Gene expression in the brain tissue was done in male Wistar rats after chronic mild stress protocol. The SRSF5 serum concentration was performed using ELISA. Data were analysed in Statistica and GraphPad.
Results:
We found an association of
STIP1
and
SRSF5
variants with major depressive disorder and
BAG1
variant with bipolar disorder. Gene expression analysis in a rat model of
depression
confirmed significant changes in the expression of
SRSF5, BAG1,
and
FKBP4
in the brain. For SRSF5, we observed significantly increased expression in the serum of depressed females and male rats exposed to chronic stress.
Conclusions:
Our results indicate the involvement of genes associated with GR function,
SRSF5, BAG1,
and
FKBP4
with susceptibility to mood disorders.
...
PMID:Genes involved in glucocorticoid receptor signalling affect susceptibility to mood disorders. 3240 Feb 87
